Monitoring Protein-Ligand Interactions in Human Cells by Real-Time Quantitative In-Cell NMR using a High Cell Density Bioreactor
March 9th, 2021
4.7K views
This protocol describes the setup of an NMR bioreactor to keep encapsulated human cells viable for up to 72 h, followed by time-resolved in-cell NMR data acquisition and analysis. The methodology is applied to monitor intracellular protein-ligand interactions in real time.
Overview
This article details the use of in-cell NMR spectroscopy combined with a specialized NMR bioreactor to monitor protein-ligand interactions and protein chemical modifications in living human cells. The described workflow enables real-time, atomic-resolution observation of intracellular processes, overcoming traditional limitations of cell viability within the NMR spectrometer. The protocol includes sample preparation, bioreactor setup, NMR data acquisition, and quantitative analysis using multivariate curve resolution (MCR-ALS).
Key Study Components
Area of Science
- Structural biology
- Cellular biochemistry
- NMR spectroscopy
Background
- In-cell NMR allows direct observation of protein structure and dynamics in living cells.
- Traditional in-cell NMR is limited by the short viability of cells in the spectrometer.
- NMR bioreactors can extend cell viability, enabling longer experiments and real-time monitoring.
- Quantitative analysis of NMR data in living cells is challenging due to complex signal overlap and dynamic changes.
Purpose of Study
- To provide a detailed protocol for using an NMR bioreactor to maintain human cells viable for extended periods during NMR experiments.
- To demonstrate real-time monitoring of protein-ligand interactions and protein modifications in living cells.
- To introduce a workflow for quantitative analysis of real-time in-cell NMR data using MCR-ALS.
Methods Used
- Preparation of transfected HEK 293T cells and embedding in agarose threads.
- Assembly and operation of a temperature-controlled NMR bioreactor with continuous medium flow.
- Real-time in-cell NMR data acquisition, including 1D and 2D experiments (e.g., SOFAST-HMQC).
- Quantitative analysis of NMR spectra using multivariate curve resolution-alternating least squares (MCR-ALS) in MATLAB.
Main Results
- The bioreactor maintained high cell viability and metabolic activity for up to 72 hours.
- Real-time monitoring of inhibitor binding (acetazolamide, methazolamide) to carbonic anhydrase in living cells was achieved.
- MCR-ALS enabled separation and quantification of free and bound protein species over time.
- The system was also used to monitor protein chemical modifications, such as disulfide bond formation in superoxide dismutase induced by ebselen.
Conclusions
- The NMR bioreactor setup allows extended, real-time in-cell NMR studies of protein-ligand interactions and modifications.
- MCR-ALS provides a robust method for quantitative analysis of complex, time-resolved NMR data in living cells.
- This approach advances the study of dynamic biological processes and drug-target interactions at atomic resolution in a cellular context.
Frequently Asked Questions
What is the main advantage of using an NMR bioreactor for in-cell NMR experiments?
The NMR bioreactor maintains high cell viability and metabolic activity for extended periods (up to 72 hours), enabling real-time monitoring of intracellular processes that are not possible with traditional in-cell NMR setups.
How are cells prepared for in-cell NMR in this protocol?
Transfected HEK 293T cells are detached, washed, and embedded in agarose threads, which are then loaded into the NMR bioreactor tube for analysis.
What types of biological processes can be monitored using this method?
The method allows observation of protein-ligand interactions, protein folding, chemical modifications, and conformational changes directly in living cells.
How is quantitative analysis of NMR data performed?
Quantitative analysis is achieved using multivariate curve resolution-alternating least squares (MCR-ALS), which separates overlapping signals and provides concentration profiles of different species over time.
What are the key considerations for maintaining cell viability in the bioreactor?
Proper temperature control, continuous medium flow, and careful handling during insertion and removal of the NMR tube are essential to avoid pressure changes and bubble formation that could compromise cell viability.
Can this protocol be applied to any protein?
The protocol is suitable for soluble, freely tumbling intracellular proteins that undergo conformational or chemical changes. Isotope labeling can further expand its applicability.
What are some example applications demonstrated in the article?
The article demonstrates real-time monitoring of inhibitor binding to carbonic anhydrase and disulfide bond formation in superoxide dismutase within living human cells.
Executive Industry Relevance
Real-time quantitative in-cell NMR using a high-density bioreactor enables direct, atomic-resolution monitoring of protein-ligand interactions and chemical modifications in living human cells. This capability addresses a critical gap in early drug discovery by providing dynamic, quantitative insights into intracellular target engagement and mechanistic processes. The approach enhances predictive confidence at the target validation and lead optimization stages, supporting risk-adjusted portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct observation of protein-ligand binding and conformational changes in a native cellular context.
- Supports mechanistic de-risking by quantifying real-time intracellular target engagement.
- Provides kinetic and concentration profiles for functional target validation.
- Facilitates triage of targets based on dynamic, quantitative readouts.
Screening & Assay Development
- Delivers validated, reproducible biological systems for downstream screening workflows.
- Enables quantitative, time-resolved assay outputs for compound evaluation.
- Supports assay standardization and platform scalability through robust bioreactor operation.
- Improves screening readiness by maintaining high cell viability and metabolic activity.
Translational & Preclinical Research
- Aligns intracellular target engagement data with disease-relevant cellular models.
- Provides continuity from discovery through preclinical validation by tracking protein modifications and interactions in real time.
- Enables risk-adjusted advancement decisions based on quantitative, cellular-level evidence.
- Supports translational biomarker development by linking molecular events to functional outcomes.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from early target validation through lead identification and preclinical research, providing a reusable platform for real-time, quantitative analysis of protein-ligand interactions in living cells.
- Discovery Biology: Supports hypothesis testing and pathway clarification by monitoring dynamic intracellular processes.
- Screening: Provides reproducible, quantitative assay outputs for compound evaluation and optimization.
- Analytics: Delivers concentration profiles and kinetic parameters via multivariate curve resolution (MCR-ALS) analysis.
- Translational Research: Bridges discovery and preclinical stages by enabling real-time monitoring in disease-relevant human cell models.
- Enterprise Reuse: Establishes a standardized, scalable workflow for repeated application across targets and programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of in-cell NMR workflows.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing quantitative, real-time data.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of discovery programs.
Implementation Considerations
- Requires expertise in NMR spectroscopy, cell culture, and quantitative data analysis.
- Needs specialized instrumentation, including a temperature-controlled NMR bioreactor and continuous medium flow system.
- Demands cross-team standardization for sample preparation, data acquisition, and analysis protocols.
- Adaptable to various soluble, freely tumbling intracellular proteins with potential for isotope labeling.
- Cell viability and metabolic activity must be carefully maintained to ensure data quality and reproducibility.
Biopharma FAQs
Why does null hypothesis testing matter for MCR-ALS kinetic analysis?
Null hypothesis testing in MCR-ALS kinetic analysis ensures that observed changes in protein-ligand binding or modification are statistically significant, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit the real-time NMR workflow?
Independent variable isolation, such as controlled ligand addition or protein expression, allows precise attribution of observed NMR signal changes to specific experimental interventions, strengthening mechanistic interpretation and workflow reliability.
What do quantitative dependent variable measurements enable in this bioreactor system?
Quantitative dependent variable measurements, including concentration profiles and kinetic parameters, enable direct comparison of free and bound protein species over time, informing compound optimization and target engagement decisions.
Why are replication requirements critical for cross-functional NMR data use?
Replication ensures that real-time NMR findings are reproducible and reliable, facilitating cross-functional collaboration between discovery, screening, and translational teams and supporting enterprise-wide data integration.
What statistical analysis capabilities are required before implementing MCR-ALS?
Robust statistical analysis capabilities, including singular value decomposition and constraint-based fitting, are essential for accurate separation and quantification of overlapping NMR signals, ensuring actionable outputs for R&D decision-making.
